LivaNova Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), 10x Genomics (TXG) and LivaNova (LIVN)
LivaNova Analyst Ratings
LivaNova: Strong Buy Rating Backed by Robust Growth and Positive Outlook
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), AnaptysBio (ANAB) and LivaNova (LIVN)
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)
Piper Sandler Keeps Their Buy Rating on LivaNova (LIVN)
LivaNova Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: LivaNova (LIVN), Vor Biopharma (VOR) and Neurogene (NGNE)
LivaNova Analyst Ratings
LivaNova's Aura6000 Poised for Success in OSA Market: A Buy Rating Overview
LivaNova Analyst Ratings
LivaNova Analyst Ratings
Baird Adjusts LivaNova's Price Target to $62 From $56, Keeps Neutral Rating
LivaNova Analyst Ratings
LivaNova Analyst Ratings
LivaNova Analyst Ratings
LivaNova (LIVN) Receives a Buy From Stifel Nicolaus
LivaNova Analyst Ratings
Analysts Conflicted on These Healthcare Names: LivaNova (LIVN), Immutep (IMMP) and Nurix Therapeutics (NRIX)